Janeta Popovici-Muller

USPTO Granted Patents = 45 (Patent Applications = 13)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 21 (Patent Applications = 20)

Average Co-Inventor Count = 7.4

ph-index = 11

Forward Citations = 335(Granted Patents)

Location History:

Waltham, MA (US) (2009 - 2022)
Windham, NH (US) (2015 - 2023)

Company Filing History:

27 out of 96

Agios Pharmaceuticals, Inc.

Servier Pharmaceuticals LLC

patents

4. 2 out of 2,405

Merck Sharp + Dohme Corp.

patents

5. 1 out of 832,680

Other

patents

Years Active: 2009-2025

Loading Chart...

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433895 - Therapeutically active compounds and their methods of use (2025-10-07),

2. 11844758 - Therapeutically active compounds and their methods of use (2023-12-19),

3. 11667673 - Therapeutically active compounds and their methods of use (2023-06-06),

4. 11524960 - Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer (2022-12-13),

5. 11505538 - Therapeutically active compounds and their methods of use (2022-11-22),

6. 11021515 - Therapeutically active compounds and their methods of use (2021-06-01),

7. 10946023 - Therapeutically active compounds and their methods of use (2021-03-16),

8. 10717764 - Therapeutically active compounds and their methods of use (2020-07-21),

9. 10689414 - Therapeutically active compounds and their methods of use (2020-06-23),

10. 10689375 - Compounds and their methods of use (2020-06-23),

11. 10640534 - Therapeutically active compositions and their methods of use (2020-05-05),

12. 10414740 - Glutaminase inhibitors and method of use (2019-09-17),

13. 10376510 - 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer (2019-08-13),

14. 10294215 - Therapeutically active compounds and their methods of use (2019-05-21),

15. 10202339 - Therapeutic compounds and compositions (2019-02-12),

Title: Innovator Spotlight: Janeta Popovici-Muller - Pioneering Cancer Therapies

Introduction:

Janeta Popovici-Muller, hailing from Windham, NH, is a renowned inventor with an impressive portfolio of 44 patents. His groundbreaking work in developing therapeutically active compounds for cancer treatment has earned him recognition in the field of medical innovation.

Latest Patents:

Popovici-Muller's latest patents revolve around therapeutically active compounds and their methods of use in treating cancer. These compounds offer new avenues for combating the disease, particularly targeting cancers with mutant alleles of IDH1/2. By administering these compounds, he has paved the way for more effective and targeted cancer therapies.

Career Highlights:

During his career, Janeta Popovici-Muller has made significant contributions while working in esteemed companies such as Agios Pharmaceuticals, Inc. and Schering Corporation. His innovative research and dedication to advancing cancer treatments have left a lasting impact on the medical community.

Collaborations:

Popovici-Muller's work has been enriched through collaborations with notable colleagues like Jeremy Mark Travins and Jeffrey O Saunders. Together, they have synergized their expertise to drive forward cutting-edge solutions for cancer therapy, fostering a culture of innovation and collaboration in the workplace.

Conclusion:

In conclusion, Janeta Popovici-Muller stands as a pioneering force in the realm of cancer research and treatment. His patented compounds and methods showcase his commitment to pushing boundaries and improving outcomes for patients battling this devastating disease. With a legacy of innovation and collaboration, Popovici-Muller continues to inspire advancements in the field of medical science.

This text is generated by artificial intelligence and may not be accurate.